James D. Griffin

2002 -- 2003 FACULTY COMMITTEES FACULTY CHAIR - W. CARSON FACULTY CHAIR ELECT - C. JENNINGS

Fac Planning, Ben Geter, Nicole Calhoun, 2003 .

MAML1, a human homologue of Drosophila Mastermind, is a transcriptional co-activator for NOTCH receptors

James D. Griffin, Jon C. Aster, Stephen C. Blacklow, 2000, Nature Genetics.

Mechanisms of Transformation by the BCR/ABL Oncogene

James D. Griffin, J. Griffin, M. Sattler, 2001, International journal of hematology.

Surface marker anaylsis of acute myeloblastic leukemia: identifi- cation of differentiation-associated phenotypes.

Robert J. Mayer, James D. Griffin, D. Rosenthal, 1983 .

Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants.

James D. Griffin, Andrew L. Kung, Taebo Sim, 2010, Blood.

Growth Suppression of Pre-T Acute Lymphoblastic Leukemia Cells by Inhibition of Notch Signaling

James D. Griffin, Andrew P. Weng, Jon C. Aster, 2003, Molecular and Cellular Biology.

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

James D. Griffin, Andreas Hochhaus, J. Griffin, 2007, Nature Reviews Cancer.

p130CAS Forms a Signaling Complex with the Adapter Protein CRKL in Hematopoietic Cells Transformed by the BCR/ABL Oncogene*

James D. Griffin, Naoki Uemura, Ravi Salgia, 1996, The Journal of Biological Chemistry.